The 13 linked references in paper M. Pokrovsky V., V. Gureev V., E. Stupakova G., O. Antsiferova E., T. Lokteva I., L. Zhilinkova A., М. Покровский В., В. Гуреев В., Е. Ступакова Г., О. Анциферова Е., Т. Локтева И., Л. Жилинкова А. (2018) “Биологические механизмы естественной цитопротекции - перспективное направление создания новых лекарственных препаратов для профилактики и лечения преэклампсии // Biological mechanisms of natural cytoprotection - a promising trend in the development of new medicines aimed at prevention and treatment of preeclampsia” / spz:neicon:vedomostincesmp:y:2016:i:4:p:20-27

  1. Scioscia M, Karumanchi SA, Goldman-Wohl D, Robillard PY. Endothelial dysfunction and metabolic syndrome in preeclampsia: analternativeviewpoint.JReprodImmunol.2015.pii: S0165–0378(15)00027–3. doi: 10.1016/j.jri.2015.01.009.
  2. Pereira RD, De Long NE, Wang RC, Yazdi FT, Holloway AC, Raha S. Angiogenesis in the Placenta: The Role of Reactive Oxygen SpeciesSignaling.BiomedResInt.2015;2015:814543.doi: 10.1155/2015/814543.
  3. Augustine MS, Rogers LK. Measurement of arginine metabolites: regulators of nitric oxide metabolism. Curr Protoc Toxicol. 2013. doi: 10.1002/0471140856.tx1716s58.
  4. Noorbakhsh M, Kianpour M, Nematbakhsh M. Serum levels of asymmetric dimethylarginine, vascular endothelial growth factor, and nitric oxide metabolite levels in preeclampsia patients. ISRN Obstet Gynecol. 2013. doi: 10.1155/2013/104213.
  5. Yi-Ping Leng, Ni Qiu, Wei-jin Fang, Mei Zhang, Zhi-Min He. Involvement of increased endogenous asymmetric dimethylarginine in the hepatic endoplasmic reticulum stress of type 2 diabetic rats. doi: 10.1371/journal.pone.0097125.
  6. Pérez-Sepúlveda A, España-Perrot PP, Fernández XB, Ahumada V, Bustos V, Arraztoa JA, et al. Levels of key enzymes of methionine-homocysteine metabolism in preeclampsia. Biomed Res Int. 2013. 2013:731962. doi: 10.1155/2013/731962.
  7. Morris CF, Tahir Ì, Arshid S, Castro MS, Fontes W. Reconciling the IPC and Two-Hit Models: Dissecting the Underlying Cellular and Molecular Mechanisms of Two Seemingly Opposing Frameworks. J Immunol Res. 2015. doi: 10.1155/2015/697193.
  8. Alleman RJ, Stewart LM, Tsang AM, Brown DA. Why Does Exercise «Trigger» Adaptive Protective Responses in the Heart? Dose Response. 2015 Jan-Mar; 13(1). doi: 10.2203/dose-response.14–023.Alleman
  9. Veighey K, Macallister RJ. Clinical applications of remote ischemic preconditioning. Cardiol Res Pract. 2012. 2012:620681. doi: 10.1155/2012/620681.
  10. Kierulf-Lassen Ñ, Kristensen ML, Birn H, Jespersen B, Nørregaard R. No Effect of Remote Ischemic Conditioning Strategies on Recovery from Renal Ischemia-Reperfusion Injury and Protective Molecular Mediators. PLoS One. 2015 Dec 31; 10(12): e0146109. doi: 10.1371/journal.pone.0146109. eCollection 2015.
  11. Morris CFM, Tahir M, Arshid S, Castro MS, Fontes W. Reconciling the IPC and Two-Hit Models: Dissecting the Underlying Cellular and Molecular Mechanisms of Two Seemingly Opposing Frameworks. J Immunol Res. 2015. doi: 10.1155/2015/697193.
  12. Ávalos R, Martinez-Sanz R, JiménezJJ, Iribarren JL, Montoto J, Lacruz A, et al. Levosimendan preconditioning in patients undergoing elective cardiac surgery with poor ejection fraction. preliminary results. J Cardiothorac Surg. 2015; 10(Suppl 1): A310. doi: 10.1186/1749–8090–10-S1-A310.
  13. Behmenburg F, Dorsch M, Huhn R, Mally D, Heinen A, Hollmann MW. Impact of Mitochondrial Ca2+-Sensitive Potassium (mBKCa) Channels in Sildenafil-Induced Cardioprotection in Rats. PLoS One. 2015 Dec 15; 10(12): e0144737. doi: 10.1371/journal.pone.0144737.